Showing results (831-840 of 5,983) with videos related to

Sort By:
Pageof 599
Molecular Cancer Therapeutics|April 18, 2009
BIIB021, an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90Karen Lundgren, Hong Zhang, John Brekken, et al.
Molecular Cancer Therapeutics|April 18, 2009
The selective hypoxia inducible factor-1 inhibitor PX-478 provides in vivo radiosensitization through tumor stromal effectsDavid L Schwartz, Garth Powis, Arun Thitai-Kumar, et al.
Molecular Cancer Therapeutics|July 9, 2009
Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibitionAnnamaria Rapisarda, Melinda Hollingshead, Badarch Uranchimeg, et al.
Molecular Cancer Therapeutics|July 9, 2009
EGFRvIII and c-Met pathway inhibitors synergize against PTEN-null/EGFRvIII+ glioblastoma xenograftsBachchu Lal, C Rory Goodwin, Yingying Sang, et al.
Molecular Cancer Therapeutics|July 9, 2009
Topoisomerase I levels in the NCI-60 cancer cell line panel determined by validated ELISA and microarray analysis and correlation with indenoisoquinoline sensitivityThomas D Pfister, William C Reinhold, Keli Agama, et al.
Molecular Cancer Therapeutics|July 9, 2009
Renal and liver tumors in Tsc2(+/-) mice, a model of tuberous sclerosis complex, do not respond to treatment with atorvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitorGeraldine A Finlay, Amy J Malhowski, Kristen Polizzi, et al.
Molecular Cancer Therapeutics|February 12, 2009
Effect of hypoxia on the expression of phosphoglycerate kinase and antitumor activity of troxacitabine and gemcitabine in non-small cell lung carcinomaWing Lam, Scott Bussom, Yung-Chi Cheng
Molecular Cancer Therapeutics|February 12, 2009
Inhibition of Akt inhibits growth of glioblastoma and glioblastoma stem-like cellsGary L Gallia, Betty M Tyler, Christine L Hann, et al.
Molecular Cancer Therapeutics|August 30, 2008
Diallyl trisulfide increases the effectiveness of TRAIL and inhibits prostate cancer growth in an orthotopic model: molecular mechanismsSharmila Shankar, Qinghe Chen, Suthakar Ganapathy, et al.
Molecular Cancer Therapeutics|August 30, 2008
Breaching the DNA damage checkpoint via PF-00477736, a novel small-molecule inhibitor of checkpoint kinase 1Alessandra Blasina, Jill Hallin, Enhong Chen, et al.
Pageof 599